Fund Evaluation Group, LLC Medtronic PLC Transaction History

Fund Evaluation Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$85.8 - $99.49 $3.05 Million - $3.54 Million	-35,600 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$85.91 - $99.17 $398,192 - $459,652	-4,635 Reduced 11.52%	35,600 $3.5 Million
Q4 2017 Feb 14, 2018	BUY	$76.93 - $83.5 $3.1 Million - $3.36 Million	40,235	40,235 $3.25 Million

2,284

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $113B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Fund Evaluation Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fund Evaluation Group, LLC with notifications on news.